Thrombotic Microangiopathies Clinical Trials

26 clinical trials for Thrombotic Microangiopathies across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients — RECRUITING
• Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura — RECRUITING · NA
• Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center — RECRUITING
• Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium — RECRUITING
• Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy — RECRUITING
• Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA — RECRUITING · PHASE2
• Longitudinal Cohort of Thrombosis and Hemostasis Diseases — RECRUITING
• Construction of a Database for TMA — RECRUITING
• The Role of interferOn and Complement in SecondAry thRombotic micrioangiOpathy — NOT_YET_RECRUITING · NA
• Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies — WITHDRAWN · PHASE3
• TGD001 Treatment in Thrombotic Microangiopathies — NOT_YET_RECRUITING · PHASE1
• Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome — TERMINATED · PHASE3
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) — WITHDRAWN · PHASE1
• Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy — TERMINATED · PHASE3
• Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies — COMPLETED · PHASE2
• Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma — WITHDRAWN · PHASE2
• Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab — OTHER
• Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients — COMPLETED · PHASE2
• Automated Surveillance, Alert, and Rapid Diagnosis of Thrombotic Microangiopathies: the ASARD-TMA Study — OTHER
• Ravulizumab and COVID-19 — OTHER · PHASE3
• Study in Adult and Pediatric Patients With HSCT-TMA — WITHDRAWN
• A Safety and Efficacy Study of NAC in Patients With TA-TMA — COMPLETED · PHASE3
• Defibrotide TMA Prophylaxis Pilot Trial — COMPLETED · PHASE2
• Early Predictive Factors of Cardiac and Cerebral Involvement in TMA — COMPLETED · NA
• TTP and aHUS in Complicated Pregnancies — OTHER
• Screening of TMA Patients für ADAMTS13 Activity (Adamscreen) — OTHER

Refine this search